Back to top

VERAXA Biotech (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

Austin, Texas, United States, June 25th, 2026, FinanceWire VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: